Shlomi Raz is the founder, chairman, and CEO of Eleusis Benefit Corporation. He earned a Bachelor of Science degree in finance from Georgetown University in 1996 and a Master of Arts in Psychology from New York University in 2012. Prior to founding Eleusis, Shlomi worked as a vice president at JP Morgan Chase and managing director at Goldman Sachs.
Shlomi is currently guiding Eleusis as they explore the therapeutic benefits of psychedelics for treating chronic inflammation and Alzheimer’s disease.
Barbara E. Bauer, MS
Barb is the former Editor and one of the founders of Psychedelic Science Review. She is currently a contributing writer. Her goal is making accurate and concise psychedelic science research assessable so that researchers and private citizens can make informed decisions.